T2 Biosystems, Inc. (NASDAQ: TTOO) Starts Presentation at the 2017 Marcum Microcap Conference
T2 Biosystems (NASDAQ: TTOO) is an emerging leader in the field of in vitro diagnostics with its FDA-cleared T2Dx® Instrument and T2Candida® Panel targeting sepsis. The company also is utilizing its proprietary T2 Magnetic Resonance technology to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables fast and sensitive detection of pathogens, biomarkers and other abnormalities in a variety of patient sample types. For more information, visit the company's website at www.t2biosystems.com About NetworkNewsWire NetworkNewsWire (NNW) is an…







